Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL

Clinical trial NCT07494565 · RECRUITING

Trial details

NCT number: NCT07494565
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B-Cell Lymphoma (DLBCL)CD5 Positive

Start date: 2026-03-06
Primary completion: 2028-03-05
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.